Novartis Investigative Site

Karachi 75300

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Renal Cell, Neoplasms, Breast, Purpura, Thrombocytopaenic, Idiopathic

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma — Completed
• EXTEND (Eltrombopag Extended Dosing Study) — Completed